Patient perception and knowledge of acetaminophen in a large family medicine service

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 28, Issue 2, 2014, Pages 109-116

  Herndon, Christopher M ^a   Dankenbring, Dawn M ^b  

^a SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

^b St Elizabeth Hospital   (United States)

Author keywords

Acetaminophen; Acute liver failure; APAP; Hepatotoxicity; Liver transplantation

Indexed keywords

ACETYLSALICYLIC ACID; IBUPROFEN; NAPROXEN; PARACETAMOL; ANALGESIC AGENT;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTHRALGIA; ARTICLE; CONVENIENCE SAMPLE; CROSS-SECTIONAL STUDY; DRUG INFORMATION; DRUG SAFETY; DRUG USE; DYSPNEA; FAMILY MEDICINE; FEMALE; HEALTH EDUCATION; HEALTH PRACTITIONER; HEALTH SURVEY; HEART FAILURE; HUMAN; KNOWLEDGE; LIVER FAILURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MAXIMUM PERMISSIBLE DOSE; MEDICAL SERVICE; MIDDLE AGED; PATIENT EDUCATION; PERCEPTION; SELF REPORT; WAITING ROOM; YOUNG ADULT; ADOLESCENT; ATTITUDE TO HEALTH; DRUG-INDUCED LIVER INJURY; GENERAL PRACTICE; INFORMATION PROCESSING;

ACETAMINOPHEN; ADOLESCENT; ADULT; AGED; ANALGESICS, NON-NARCOTIC; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DRUG-INDUCED LIVER INJURY; FAMILY PRACTICE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PERCEPTION; YOUNG ADULT;

EID: 84901980254     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.3109/15360288.2014.908993     Document Type: Article

References (25)

1. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287:337-344. (Pubitemid 34251967)
2. Vernacchio L,Kelly JP, KaufmanDW,Mitchell AA. Medication use among children<12 years of age in theUnited States: results from the Slone Survey. Pediatrics. 2009;124:446-454.
3. Larson AM. Acetaminophen hepatotoxicity. Clin Liver Dis. 2007;11:525-548, vi.
4. Larson AM, Polson J, Fontana RJ, et al. Acetaminopheninduced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364-1372.
5. Goyal RK, Rajan SS, Essien EJ, Sansgiry SS. Effectiveness of FDA's new over-the-counter acetaminophen warning label in improving consumer risk perception of liver damage. J Clin Pharm Ther. 2012;37:681-685.
6. Schilling A, Corey R, LeonardM, Eghtesad B. Acetaminophen: old drug, new warnings. Cleveland Clin J Med. 2010;77:19-27.
7. Turkoski BB. Acetaminophen: old friend - new rules. Orthopaed Nurs. 2010;29:41-43; quiz 4-5.
8. Krenzelok EP, Royal MA. Confusion: acetaminophen dosing changes based on NO evidence in adults. Drugs R&D. 2012;12:45-48.
9. Fabiny A. (ed.) Food and Drug Administration Information on Acetaminophen. (2011). Available from: http://www.fda.gov/ drugs/drugsafety/ informationbydrugclass/ucm165107.htm. Accessed May 2, 2014.
10. Graham GG, Day RO, Graudins A, Mohamudally A. FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable? Inflammopharmacology. 2010;18:47-55.
11. Krenzelok EP. The FDA Acetaminophen Advisory Committee Meeting - what is the future of acetaminophen in the United States? The perspective of a committee member. Clin Toxicol. 2009;47:784-789.
12. Kuehn BM. FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen. JAMA. 2009;302:369-371.
13. DeDea L. FDA limits acetaminophen; risk of death with tigecycline. JAAPA. 2012;25:16.
14. Stumpf JL, Skyles AJ, Alaniz C, Erickson SR. Knowledge of appropriate acetaminophen doses and potential toxicities in an adult clinic population. J Am Pharm Assoc. 2007;47:35-41.
15. Hornsby LB, Whitley HP, Hester EK, Thompson M, Donaldson A. Survey of patient knowledge related to acetaminophen recognition, dosing, and toxicity. J Am Pharm Assoc. 2010;50:485-489.
16. Hurwitz J, Sands S, Davis E, Nielsen J, Warholak T. Patient knowledge and use of acetaminophen in over-the-counter medications. JAPHA. 2014;54:19-26.
17. Food and Drug Administration. Acetaminophen and liver injury. URL: http://www.fda.gov/downloads/ForConsumers/ ConsumerUpdates/UCM172664.pdf. Accessed May 2, 2014.
18. Advisory Committee Meeting - liver injury related to the use of acetaminophen. 2009. Available at http://www.fda. gov/drugs/drugsafety/ informationbydrugclass/ucm165107.htm. Accessed January 5, 2014
19. Bower WA, Johns M, Margolis HS, Williams IT, Bell BP. Population-based surveillance for acute liver failure. Am J Gastroenterol. 2007;102:2459-2463. (Pubitemid 47631759)
20. Hawton K, Bergen H, Simkin S, et al. Impact of different pack sizes of paracetamol in the United Kingdom and Ireland on intentional overdoses: a comparative study. BMC Public Health. 2011;11:460.
21. Hawton K, Bergen H, Simkin S, et al. Long term effect of reduced pack sizes of paracetamol on poisoning deaths and liver transplant activity in England andWales: interrupted time series analyses. BMJ. 2013;346:f403.
22. Hawton K, Townsend E, Deeks J, et al. Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ. 2001;322:1203-1207. (Pubitemid 32453064)
23. Turvill JL, Burroughs AK,Moore KP. Change in occurrence of paracetamol overdose in UK after introduction of blister packs. Lancet. 2000;355:2048-2049. (Pubitemid 30339246)
24. Sheen CL, Dillon JF, Bateman DN, Simpson KJ, MacDonald TM. Paracetamol pack size restriction: the impact on paracetamol poisoning and the over-the-counter supply of paracetamol, aspirin and ibuprofen. Pharmacoepidemiol Drug Saf. 2002;11:329-331. (Pubitemid 34704733)
25. Network Organ Procurement and Transplant Network. National Data. Washington, DC: Department of Health and Human Services; 2013.